Global Gefitinib Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview

• 1.1 Gefitinib Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 10 Tables/Box
  • 1.2.2 30 Tables/Box
  • 1.2.3 90 Tables/Box
• 1.3 Market Analysis by Applications
  • 1.3.1 Hospital
  • 1.3.2 Clinic
  • 1.3.3 Drug Center
  • 1.3.4 Other
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
    • 1.4.1.1 United States Market States and Outlook (2014-2024)
    • 1.4.1.2 Canada Market States and Outlook (2014-2024)
    • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2014-2024)
    • 1.4.2.2 France Market States and Outlook (2014-2024)
    • 1.4.2.3 UK Market States and Outlook (2014-2024)
    • 1.4.2.4 Russia Market States and Outlook (2014-2024)
    • 1.4.2.5 Italy Market States and Outlook (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2014-2024)
    • 1.4.3.2 Japan Market States and Outlook (2014-2024)
    • 1.4.3.3 Korea Market States and Outlook (2014-2024)
    • 1.4.3.4 India Market States and Outlook (2014-2024)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
    • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
    • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
    • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 AstraZeneca
  • 2.1.1 Business Overview
  • 2.1.2 Gefitinib Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 AstraZeneca Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Qilu Pharmaceutical
  • 2.2.1 Business Overview
  • 2.2.2 Gefitinib Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Qilu Pharmaceutical Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Natco Pharma
  • 2.3.1 Business Overview
  • 2.3.2 Gefitinib Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Natco Pharma Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Celon Laboratories
  • 2.4.1 Business Overview
  • 2.4.2 Gefitinib Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Celon Laboratories Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Hetero Drugs
  • 2.5.1 Business Overview
  • 2.5.2 Gefitinib Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Hetero Drugs Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Dr Reddy's Laboratories
  • 2.6.1 Business Overview
  • 2.6.2 Gefitinib Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Dr Reddy's Laboratories Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Zuventus Healthcare
  • 2.7.1 Business Overview
  • 2.7.2 Gefitinib Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Zuventus Healthcare Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 United Biotech
  • 2.8.1 Business Overview
  • 2.8.2 Gefitinib Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 United Biotech Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Panacea Biotec
  • 2.9.1 Business Overview
  • 2.9.2 Gefitinib Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Panacea Biotec Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Cipla
  • 2.10.1 Business Overview
  • 2.10.2 Gefitinib Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Cipla Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Glenmark Pharmaceuticals
  • 2.11.1 Business Overview
  • 2.11.2 Gefitinib Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Glenmark Pharmaceuticals Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Nobel Ilac Sanayii Ve Ticaret
  • 2.12.1 Business Overview
  • 2.12.2 Gefitinib Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Accure Labs
  • 2.13.1 Business Overview
  • 2.13.2 Gefitinib Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Accure Labs Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Cadila Pharmaceuticals
  • 2.14.1 Business Overview
  • 2.14.2 Gefitinib Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Cadila Pharmaceuticals Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Ethypharm
  • 2.15.1 Business Overview
  • 2.15.2 Gefitinib Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Ethypharm Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 Flagship Biotech International
  • 2.16.1 Business Overview
  • 2.16.2 Gefitinib Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 Flagship Biotech International Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.17 Globela Pharma
  • 2.17.1 Business Overview
  • 2.17.2 Gefitinib Type and Applications
    • 2.17.2.1 Product A
    • 2.17.2.2 Product B
  • 2.17.3 Globela Pharma Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.18 Jodas Expoim
  • 2.18.1 Business Overview
  • 2.18.2 Gefitinib Type and Applications
    • 2.18.2.1 Product A
    • 2.18.2.2 Product B
  • 2.18.3 Jodas Expoim Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.19 Nishchay Pharmaceuticals
  • 2.19.1 Business Overview
  • 2.19.2 Gefitinib Type and Applications
    • 2.19.2.1 Product A
    • 2.19.2.2 Product B
  • 2.19.3 Nishchay Pharmaceuticals Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.20 Sichuan Xieli Pharmaceutical
  • 2.20.1 Business Overview
  • 2.20.2 Gefitinib Type and Applications
    • 2.20.2.1 Product A
    • 2.20.2.2 Product B
  • 2.20.3 Sichuan Xieli Pharmaceutical Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Gefitinib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

• 3.1 Global Gefitinib Sales and Market Share by Manufacturer (2017-2018)
• 3.2 Global Gefitinib Revenue and Market Share by Manufacturer (2017-2018)
• 3.3 Market Concentration Rate
  • 3.3.1 Top 3 Gefitinib Manufacturer Market Share in 2018
  • 3.3.2 Top 6 Gefitinib Manufacturer Market Share in 2018
• 3.4 Market Competition Trend

4 Global Gefitinib Market Analysis by Regions

• 4.1 Global Gefitinib Sales, Revenue and Market Share by Regions
  • 4.1.1 Global Gefitinib Sales and Market Share by Regions (2014-2019)
  • 4.1.2 Global Gefitinib Revenue and Market Share by Regions (2014-2019)
• 4.2 North America Gefitinib Sales and Growth Rate (2014-2019)
• 4.3 Europe Gefitinib Sales and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Gefitinib Sales and Growth Rate (2014-2019)
• 4.5 South America Gefitinib Sales and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Gefitinib Sales and Growth Rate (2014-2019)

5 North America Gefitinib by Country

• 5.1 North America Gefitinib Sales, Revenue and Market Share by Country
  • 5.1.1 North America Gefitinib Sales and Market Share by Country (2014-2019)
  • 5.1.2 North America Gefitinib Revenue and Market Share by Country (2014-2019)
• 5.2 United States Gefitinib Sales and Growth Rate (2014-2019)
• 5.3 Canada Gefitinib Sales and Growth Rate (2014-2019)
• 5.4 Mexico Gefitinib Sales and Growth Rate (2014-2019)

6 Europe Gefitinib by Country

• 6.1 Europe Gefitinib Sales, Revenue and Market Share by Country
  • 6.1.1 Europe Gefitinib Sales and Market Share by Country (2014-2019)
  • 6.1.2 Europe Gefitinib Revenue and Market Share by Country (2014-2019)
• 6.2 Germany Gefitinib Sales and Growth Rate (2014-2019)
• 6.3 UK Gefitinib Sales and Growth Rate (2014-2019)
• 6.4 France Gefitinib Sales and Growth Rate (2014-2019)
• 6.5 Russia Gefitinib Sales and Growth Rate (2014-2019)
• 6.6 Italy Gefitinib Sales and Growth Rate (2014-2019)

7 Asia-Pacific Gefitinib by Country

• 7.1 Asia-Pacific Gefitinib Sales, Revenue and Market Share by Country
  • 7.1.1 Asia-Pacific Gefitinib Sales and Market Share by Country (2014-2019)
  • 7.1.2 Asia-Pacific Gefitinib Revenue and Market Share by Country (2014-2019)
• 7.2 China Gefitinib Sales and Growth Rate (2014-2019)
• 7.3 Japan Gefitinib Sales and Growth Rate (2014-2019)
• 7.4 Korea Gefitinib Sales and Growth Rate (2014-2019)
• 7.5 India Gefitinib Sales and Growth Rate (2014-2019)
• 7.6 Southeast Asia Gefitinib Sales and Growth Rate (2014-2019)

8 South America Gefitinib by Country

• 8.1 South America Gefitinib Sales, Revenue and Market Share by Country
  • 8.1.1 South America Gefitinib Sales and Market Share by Country (2014-2019)
  • 8.1.2 South America Gefitinib Revenue and Market Share by Country (2014-2019)
• 8.2 Brazil Gefitinib Sales and Growth Rate (2014-2019)
• 8.3 Argentina Gefitinib Sales and Growth Rate (2014-2019)
• 8.4 Colombia Gefitinib Sales and Growth Rate (2014-2019)

9 Middle East and Africa Gefitinib by Countries

• 9.1 Middle East and Africa Gefitinib Sales, Revenue and Market Share by Country
  • 9.1.1 Middle East and Africa Gefitinib Sales and Market Share by Country (2014-2019)
  • 9.1.2 Middle East and Africa Gefitinib Revenue and Market Share by Country (2014-2019)
• 9.2 Saudi Arabia Gefitinib Sales and Growth Rate (2014-2019)
• 9.3 Turkey Gefitinib Sales and Growth Rate (2014-2019)
• 9.4 Egypt Gefitinib Sales and Growth Rate (2014-2019)
• 9.5 Nigeria Gefitinib Sales and Growth Rate (2014-2019)
• 9.6 South Africa Gefitinib Sales and Growth Rate (2014-2019)

10 Global Gefitinib Market Segment by Type

• 10.1 Global Gefitinib Sales, Revenue and Market Share by Type (2014-2019)
  • 10.1.1 Global Gefitinib Sales and Market Share by Type (2014-2019)
  • 10.1.2 Global Gefitinib Revenue and Market Share by Type (2014-2019)
• 10.2 10 Tables/Box Sales Growth and Price
  • 10.2.1 Global 10 Tables/Box Sales Growth (2014-2019)
  • 10.2.2 Global 10 Tables/Box Price (2014-2019)
• 10.3 30 Tables/Box Sales Growth and Price
  • 10.3.1 Global 30 Tables/Box Sales Growth (2014-2019)
  • 10.3.2 Global 30 Tables/Box Price (2014-2019)
• 10.4 90 Tables/Box Sales Growth and Price
  • 10.4.1 Global 90 Tables/Box Sales Growth (2014-2019)
  • 10.4.2 Global 90 Tables/Box Price (2014-2019)

11 Global Gefitinib Market Segment by Application

• 11.1 Global Gefitinib Sales Market Share by Application (2014-2019)
• 11.2 Hospital Sales Growth (2014-2019)
• 11.3 Clinic Sales Growth (2014-2019)
• 11.4 Drug Center Sales Growth (2014-2019)
• 11.5 Other Sales Growth (2014-2019)

12 Gefitinib Market Forecast (2019-2024)

• 12.1 Global Gefitinib Sales, Revenue and Growth Rate (2019-2024)
• 12.2 Gefitinib Market Forecast by Regions (2019-2024)
  • 12.2.1 North America Gefitinib Market Forecast (2019-2024)
  • 12.2.2 Europe Gefitinib Market Forecast (2019-2024)
  • 12.2.3 Asia-Pacific Gefitinib Market Forecast (2019-2024)
  • 12.2.4 South America Gefitinib Market Forecast (2019-2024)
  • 12.2.5 Middle East and Africa Gefitinib Market Forecast (2019-2024)
• 12.3 Gefitinib Market Forecast by Type (2019-2024)
  • 12.3.1 Global Gefitinib Sales Forecast by Type (2019-2024)
  • 12.3.2 Global Gefitinib Market Share Forecast by Type (2019-2024)
• 12.4 Gefitinib Market Forecast by Application (2019-2024)
  • 12.4.1 Global Gefitinib Sales Forecast by Application (2019-2024)
  • 12.4.2 Global Gefitinib Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

• 13.1 Sales Channel
  • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
• 13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

• 15.1 Methodology